Description

HMG 75iu × 10 vials

A gonadotropin preparation studied for reproductive-hormone research, follicle-stimulating hormone activity, luteinizing hormone activity, ovarian follicle development models, spermatogenesis research, endocrine signaling, and fertility-related research protocols.

Product Overview

Compound: HMG / Human Menopausal Gonadotropin
Strength: 75 IU per vial
Injection type: Research protocol dependent
Frequency: Research protocol dependent

Reconstitution

Amount in vial: 75 IU
BAC water: 2 mL
Amount per unit: 0.375 IU per unit

Research Dose

Protocol dependent.

Notes

HMG, or Human Menopausal Gonadotropin, is described as a gonadotropin preparation containing follicle-stimulating hormone activity and luteinizing hormone activity. These hormones are involved in reproductive endocrine signaling and are commonly studied in fertility-related research models.

Research literature has examined HMG in relation to ovarian follicle development, ovulation-related pathways, spermatogenesis, Leydig cell activity, testosterone-production signaling, and broader hypothalamic-pituitary-gonadal axis regulation.

HMG is primarily associated with reproductive-hormone research and should not be treated as a general wellness, performance, or cosmetic peptide.

Most available evidence comes from clinical and reproductive-medicine research contexts. No standard consumer dosing protocol should be assumed.

Use only within appropriate research or professional guidance frameworks.